share_log

Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Aug 3, 2023 13:40
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more